Agios Pharmaceuticals
AGIO
#5052
Rank
A$2.43 B
Marketcap
A$41.75
Share price
1.13%
Change (1 day)
-56.65%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2025 (TTM): A$69.64 Million

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is A$67.43 Million. In 2024 the company made a revenue of A$58.67 Million an increase over the revenue in the year 2023 that were of A$39.37 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$69.64 M18.69%
2024 A$58.67 M49.04%
2023 A$39.37 M88.14%
2022 A$20.92 M
2021 N/A-100%
2020 A$57.28 M-65.99%
2019 A$0.16 B25.7%
2018 A$0.13 B143.19%
2017 A$55.09 M-43.18%
2016 A$96.96 M19.48%
2015 A$81.15 M1.62%
2014 A$79.86 M178.83%
2013 A$28.64 M18.56%
2012 A$24.15 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Xencor
XNCR
A$0.25 B 273.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
A$3.44 B 5,008.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$94.52 B 140,075.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.65 B 6,807.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$63.76 B 94,456.44%๐Ÿ‡ฌ๐Ÿ‡ง UK
Eli Lilly
LLY
A$89.45 B 132,560.13%๐Ÿ‡บ๐Ÿ‡ธ USA